| Literature DB >> 27733132 |
Saga Elise Mariansdatter1, Andreas Halgreen Eiset2, Kirstine Kobberøe Søgaard2, Christian Fynbo Christiansen2.
Abstract
BACKGROUND: Sepsis and severe sepsis are common conditions in hospital settings, and are associated with high rates of morbidity and mortality, but reported incidences vary considerably. In this literature review, we describe the variation in reported population-based incidences of sepsis and severe sepsis. We also examine methodological and demographic differences between studies that may explain this variation.Entities:
Keywords: Epidemiology; Incidence; Method; Review; SIRS; Sepsis; Septicaemia; Severe sepsis
Mesh:
Year: 2016 PMID: 27733132 PMCID: PMC5062833 DOI: 10.1186/s12874-016-0237-9
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Criteria proposed to define sepsis and severe sepsis; comparison of guidelines
|
| Bone | Levy | Dellinger | Singer | ||||
|
| I |
| ||||||
| General parameters | Core temperature | >38°C | >38.3°C |
| ||||
| Heart rate | >90 bpm | >90 bpm or >2 SD above the normal value for age |
| |||||
| Tachypnea | >20 breaths per minute | No specification |
| |||||
| Mental status | – | Altered mental status | Glasgow coma scale: | SOFA score: | ||||
| 13-14 | 1 | |||||||
| 10-12 | 2 | |||||||
| 6-9 | 3 | |||||||
| <6 | 4 | |||||||
| Significant edema or positive fluid balance | – | >20 mL/kg over 24 hrs |
| |||||
| Hyperglycemia in the absence of diabetes | – | Plasma glucose >120 mg/dL | Plasma glucose >140 mg/dL |
| ||||
| Inflammatory parameters | White blood cell count | >12,000/cu mm (leukocytosis) | >12,000/μL (leukocytosis) |
| ||||
| Plasma C reactive protein | – | >2 SD above the normal value |
| |||||
| Plasma procalcitonin | – | >2 SD above the normal value |
| |||||
| Hemodynamic parameters | Arterial hypotension | – | SBP <90 mmHg | MAP or administration of vasopressors (μg/kg/min): | SOFA score: | |||
| MAP < 70 mm/Hg | 1 | |||||||
| dop ≤ 5 or dob (any dose) | 2 | |||||||
| dop > 5 or epi ≤ 0.1 or nor ≤ 0.1 | 3 | |||||||
| dop > 15 or epi > 0.1 or nor > 0.1 | 4 | |||||||
| Mixed venous oxygen saturation | – | >70% | – |
| ||||
| Cardiac index | – | >3.5 L/min/m2 | – |
| ||||
| Organ dysfunction parameters | Arterial hypoxemia | – | PaO2/FIO2 <300 | PaO2/FIO2: | SOFA score: | |||
| <400 | 1 | |||||||
| <300 | 2 | |||||||
| <200 and mechanically ventilated | 3 | |||||||
| <100 and mechanically ventilated | 4 | |||||||
| Acute oliguria | – | Urine output <0.5 mL/kg/hr or 45 mmol/L for at least 2 hrs | Urine output <0.5 mL/kg/hr for at least 2 hrs despite adequate fluid resuscitation | Creatinine (mg/dl) [μmol/L] | SOFA score: | |||
| 1.2–1.9 [110-170] | 1 | |||||||
| 2.0–3.4 [171-299] | 2 | |||||||
| 3.5–4.9 [300-440] (or < 500 mL/d) | 3 | |||||||
| > 5.0 [> 440] (or < 200 mL/d) | 4 | |||||||
| Creatinine increase | – | >0.5 mg/dL | >0.5 mg/dL or 44.2 μmol/L | |||||
| Coagulation abnormalities | – | INR >1.5 or aPTT >60 s |
| |||||
| Ileus | – | Absent bowel sounds |
| |||||
| Thrombocytopenia | – | Platelet count <100 x 109/L | Platelets x 103/μL: | SOFA score: | ||||
| < 150 | 1 | |||||||
| < 100 | 2 | |||||||
| < 50 | 3 | |||||||
| < 20 | 4 | |||||||
| Hyperbilirubinemia | – | Plasma total bilirubin >4 mg/dL or 70 mmol/L | Bilirubin (mg/dl) [μmol/L]: | SOFA score: | ||||
| 1.2–1.9 [> 20-32] | 1 | |||||||
| 2.0–5.9 [33-101] | 2 | |||||||
| 6.0–11.9 [102-204] | 3 | |||||||
| > 12.0 [> 204] | 4 | |||||||
| Tissue perfusion parameters | Hyperlactatemia | – | >1 mmol/L |
| ||||
| Capillary refill | – | Decreased capillary refill or mottling |
| |||||
|
| Bone | Dellinger | Singer | |||||
|
|
|
| ||||||
| Hypo-perfusion | Hypotension (sepsis-induced), in the absence of other causes | Systolic blood pressure < 90 mmHg | As defined for sepsis |
| ||||
| Lactate | Lactic acidosis | Lactate above upper limit of laboratory normal |
| |||||
| Organ failure | Kidney injury | Oliguria | As defined for sepsis |
| ||||
| Acute lung injury | – | Pneumonia not the infectious source: PaO2/FIO2 < 250 |
| |||||
| Liver injury | – | As defined for sepsis |
| |||||
| Mental status | Acute alteration | As defined for sepsis |
| |||||
| Septic shock | Hypotension despite adequate fluid resuscitation along with the presence of perfusion abnormalities, as listed above. | Hypotension not reversed with fluid resuscitation. | Sepsis with persisting hypotension requiring vasopressors to maintain MAP ≥65 mmHg and having a serum lactate level >2 mmol/L (18mg/dL) despite adequate volume resuscitation. | |||||
| Multiple organ dysfunction syndrome (MODS) | Altered organ dysfunction in an acutely ill patient such that homeostasis cannot be maintained without intervention. | – |
| |||||
Fig. 1Flow chart of study selection
Chart-based studies of sepsis and severe sepsis incidence in the general population
| Padkin, 2003 [ | Finfer, 2004 [ | Brun-Buisson, 2004 [ | Harrison, 2006 [ | Esteban, 2007 [ | Karlsson, 2007 [ | Blanco, 2008 [ | Vesteinsdottir, 2011 [ | Davis, 2011 [ | Nygard, 2014 [ | Henriksen, 2015 [ | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Country/region | England, Wales and Northern Ireland | Australia and New Zealand | France | England, Wales and Northern Ireland | Madrid, Spain | Finland | Castilla y Leòn Region, Spain | Iceland | Northern territory, Australia | Norway | Denmark |
| Setting | 91 ICUs | 23 ICUs | 206 ICUs | 172 ICUs | 3 hospitals | 24 ICUs/11 hospitals | 11 ICUs | 3 ICUs | 1 hospital | 3 ICUs | 1 ED |
| Study population | 56,673 | 5,878 | 3,738 | 343,860 | 15,852 | 4,500 | 2,619 | 1,524 | 15,963 | NA | 8,358 |
| Number of cases (sepsis/severe sepsis) | NA/15,362 | NA/691 | NA/621 | NA/92,672 | 702/199 | NA/472 | NA/246 | NA/115 | 1,191/272 | NA/220 | 621/1,071 |
| Study duration | 1995–2000 | 3 months | 2 weeks | 10 year | 4 months | 4 months | 6 months | 1 year | 1 year | 1 year | 1 year |
| Exclusion criteria | <16 years, readmissions, sepsis not present within 24 h from admission | <15 years | <16 years, readmissions, sepsis not present within 24 h from admission | < 18 years | < 18 years, readmissions | <18 years | < 18 years, readmissions, sepsis not present on admission | < 15 years | < 15 years, severe sepsis not present within 24 h from admission, transferred with diagnosis of severe sepsis | < 15 years, readmissions, immediately preceding hospitalisation | |
| Sepsis inclusion criteria | PROWESS | Bone criteria | Bone criteria | PROWESS | Bone criteria | Bone criteria | Bone criteria | Bone criteria | PROWESS | Bone criteria | Bone criteria |
| Organ failure inclusion criteria | Modified PROWESS | Modified PROWESS | SOFA score ≥3 | Modified PROWESS | MODS score >2 | SOFA score ≥3 | Modified PROWESS | Modified Bone criteria | PROWESS | Modified Levy et al. | Protocol specified criteria |
| Calendar yeari | 1997ii | 1999 | 2001 | 1996; 2003 | 2003 | 2005 | 2002 | 2009 | 2008 | 2008 | 2011 |
| Sepsis incidence | – | – | – | – | 367 | – | – | – | 1,180 | – | 265 |
| Severe sepsis incidence | 51 | 77 | 95 | 46; 66 | 104 | 38 | 25 | 48 | 130 | 50 | 457 |
Characteristics of chart based studies of sepsis and severe sepsis incidence extrapolated to the general population. i) If study is conducted in two consecutive calendar years the last year is reported. ii) If full data were not available for 1997, the closest full year’s data were used. Abbreviations: −, not calculated; ED emergency department, hrs hours, ICU intensive care unit, MODS multiple organ dysfunction syndrome, NA not available, PROWESS Protein C Worldwide Evaluation in Severe Sepsis, SOFA, sequential organ failure assessment, yrs years old
Code-based studies of sepsis and severe sepsis incidence in the general population
| CDC, 1990 [ | Angus, 2001 [ | Martin, 2003 [ | Flaatten, 2004 [ | Dombrovskiy, 2005 [ | Esper, 2006 [ | Dombrovskiy, 2007 [ | Shen, 2010 [ | Wilhelms, 2010 [ | Kumar, 2011 [ | Lagu, 2012 [ | Chen, 2013 [ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Country/Region | USA | USA (7 states) | USA | Norway | New Jersey, USA | USA | USA | Taiwan | Sweden | USA | USA | Taiwan |
| Coding system | ICD-9 | ICD-9 | ICD-9 | ICD-10 | ICD-9 | ICD-9 | ICD-9 | ICD-9 | ICD-9/10vi | ICD-9 | ICD9 | ICD9 |
| Data source | NHDS | Constructed database | NHDS | NPR | New Jersey SID | NHDS | NIS | NHIRD | SHDR | NIS | NIS | NHIRD |
| Study population | NA | 6,621,559 | NA | 700,107 | 7,364,550 | NA | NA | 201,657iv
| 2,024,793 | NA | NA | NA |
| Number of cases (sepsis/severe sepsis) | NA | NA/192,980 | NA | 6665/NA | 24,765 - 30,081/8096 - 13,453 | NA | NA | NA/7531iv
| NA/37,990vii
| NA | NA | NA/40,856 - 116,749 |
| Exclusion criteria | <1 year | Neonate sepsis | <18 years | Previous episode of severe sepsis | Neonate sepsis, previous episode of severe sepsis | <18 years | <18 years | |||||
| Internal validation | No | Yes | Yes | No | No | (Yes)ii | No | Yes | No | No | No | No |
| Calendar year | 1979; 1987 | 1995 | 1979; 2000 | 1999 | 1995–2002 | 1979; 2003 | 1993–2003 | 1997; 2006 | 1987; 2005 | 2000; 2007 | 2007 | 1997-2008 |
| Sepsis incidence | 74; 176 | – | 83; 240i | 149 | – | 83; 275i | – | – | – | – | – | - |
| Severe sepsis incidence | – | 300 | – | – | 135–208 | – | 65–135 | 153; 359iii,iv
| 10; 35vii
| 143; 343 | 1074viii
| 188 - 507 |
Characteristics of code based studies of sepsis and severe sepsis incidence extrapolated to the general population. i) Age-standardized to fit the population distribution in the 2000 U.S. consensus. ii) Method validated by Martin et al. iii) Age-standardized using 2000 world population reported by WHO as standard. iv) No exclusion criteria. v) Exclusion criteria as stated. vi) Discharge diagnoses were classified according to ICD-9 until the end of 1996. These were translated into ICD-10 for the methods of Angus et al. and Martin et al. vii) Using the method proposed in Angus et al., Flaaten et al. (time of incidence measure: 1997; 2005) and Martin et al., respectively. viii) Using the method proposed in Angus et al. and Dombrovskiy et al., respectively. Abbreviations: −, not calculated; SHDR Swedish hospital discharge register, NA not available, NHDS national hospital discharge survey (USA), NHIRD national health insurance research (Taiwan), NIS nationwide inpatient sample (USA), NPR Norwegian patient register; yrs, years
Fig. 2Incidence over time. Each study is identified by colour and symbol
Fig. 3Boxplot of the incidence of sepsis and severe sepsis stratified on World Bank region. The figure gives a crude estimate of the median, the interquartile range (IQR), and the highest and lowest value within 1.5 × IQR. Data beyond the end of the whiskers are plotted as black points. Points represent single observations that contribute data to the estimate; colours indicate whether the study is chart- or code-based